Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1209 of 5804
-
Could a simple drug shield organs after aortic tear surgery?
Disease control Not yet recruitingThe goal of this multicenter, double-blind, randomized controlled trial is to learn if sivelestat sodium (Siv) can protect the organ function in patients suffered operation for acute type A aortic dissection. The main questions it aims to answer are: * Can the 3-day-treatment of…
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:02 UTC
-
New pill aims to ease burning nerve pain in diabetes
Symptom relief Not yet recruitingThis is a multi-center, randomized, double-blind, placebo-controlled study design evaluating the safety, efficacy, and PK parameter of HL-1186 tablet for diabetic peripheral neuropathic pain.
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Symptom relief
Last updated Jun 26, 2026 14:42 UTC
-
Could everyday tasks help stroke survivors recover arm function?
Symptom relief Not yet recruitingPeople with stroke often experience limitations in motor functions and activity participation. Occupation-based bilateral upper limb training (OBBT) using occupations as meaningful daily activities, and as part of the therapy. The activities in OBBT are tailored to the patient's …
Phase: NA • Sponsor: Hamad Medical Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
AR goggles join the fight against PTSD in veterans
Symptom relief Recruiting nowThe goal of this trial is to test how augmented reality exposure therapy (ARET) may potentiate the effects of traditional exposure therapy administered to U.S. military personnel diagnosed with PTSD. 40 adult males and females over the age of 18 that have served, or are currently…
Phase: NA • Sponsor: Wayne State University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Painting and clay may boost brain and hand function in Alzheimer's patients
Symptom relief Not yet recruitingThis randomized controlled trial aims to investigate the effects of art therapy on cognitive functions and hand functions in individuals with Alzheimer's disease. Alzheimer's disease is a progressive neurodegenerative disorder characterized by decline in memory, executive functio…
Phase: NA • Sponsor: Fenerbahce University • Aim: Symptom relief
Last updated Jun 26, 2026 15:03 UTC
-
App alerts could slash stroke comeback risk
Disease control Not yet recruitingThis study employs individualized temperature health risk early warning and risk factor management interventions for stroke, and explores their actual intervention effects. This enables patients to promptly understand their own risk levels and take corresponding protective measur…
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 26, 2026 13:32 UTC
-
New malaria vaccine vivaxin enters first human tests
⭐️ VACCINE ⭐️ Not yet recruitingPhase 1 clinical trial to evaluate the safety, reactogenicity, and immunogenicity of a malaria vaccine named Vivaxin against the protozoan Plamodium vivax in participants with no prior malaria infection
Phase: PHASE1 • Sponsor: Federal University of Minas Gerais • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 17:21 UTC
-
Can a gentle breathing aid at birth save tiny lungs?
Disease control ENROLLING_BY_INVITATIONBackground When babies are born too early (preterm), their lungs are often not fully developed. They may have trouble breathing because their airways and chest are not strong enough, and their lungs don't make enough surfactant (a natural substance that keeps the lungs open). Th…
Phase: NA • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Disease control
Last updated Jun 26, 2026 14:40 UTC
-
New injection aims to tame kidney disease
Disease control Not yet recruitingThis study is divided into two parts (Part A and Part B). This study aims to evaluate the safety and efficacy of CM313 in subjects with primary Immunoglobulin A nephropathy(IgAN), while also observing its Pharmacokinetics(PK) characteristics, Pharmacokinetics(PD) effects, and imm…
Phase: PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Jun 26, 2026 18:51 UTC
-
New hope for liver cancer: drug targets tumors resistant to immunotherapy
Disease control Not yet recruiting1. To investigate the efficacy and safety of cabozantinib in patients with progressive HCC after ICI-based combination treatment. 2. To explore potential tissue and peripheral blood biomarkers associated with clinical benefits of cabozantinib, and resistance mechanisms of prior I…
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jun 26, 2026 12:37 UTC
-
New hope for bile duct cancer: experimental drug combo enters Mid-Stage trial
Disease control Not yet recruitingThis is an open-label, multicenter Phase II clinical study aimed at evaluating the efficacy, safety, PK profile, and immunogenicity of QLS31905 for Injection combined with Chemotherapy ± QL2107 in Patients with CLDN18.2-positive Advanced Biliary Tract Cancer
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 12:50 UTC
-
Zapping the brain to unlock lost words after stroke
Symptom relief Recruiting nowThe investigator proposes to examine the effects of excitatory transcranial magnetic stimulation (TMS) combined with semantic feature analysis (SFA) language therapy to improve word-finding abilities in stroke survivors with aphasia (SWA).
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
New wearable could spot lung fluid before symptoms worsen
Diagnosis Recruiting nowThis study investigates a portable thoracic bioimpedance tomography (TBIT) device designed to detect early lung congestion in heart failure patients. The main goal is to evaluate how well the device's measurements match those obtained from lung ultrasound and other imaging techni…
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer
Disease control Recruiting nowThis is a Danish national multicenter prospective cohort study to evaluate if fluorescence-guided surgery (FGS) using indocyanine green (ICG) can reduce the rate of positive margins following sarcoma resection.
Phase: NA • Sponsor: University of Aarhus • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New injection shows promise for tough lymphoma cases
Disease control Recruiting nowThis is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability and preliminary efficacy of KSV01 Injection for patients with diffuse large B-cell lymphoma.
Phase: PHASE1 • Sponsor: TCRx Therapeutics Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a simple scan reveal which cancers are hiding a dangerous protein?
Diagnosis Recruiting nowThe project aims to perform integrated PET/MR or PET/CT imaging in patients with histologically confirmed or clinically suspected gastric cancer, pancreatic cancer, cholangiocarcinoma, or other malignant tumors with high Claudin18.2 (CLDN18.2) expression, as well as healthy volun…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
AI could predict which heart patients need extra care after stent surgery
Knowledge-focused Recruiting nowCoronary artery disease remains a leading cause of global mortality. Although percutaneous coronary intervention (PCI) improves patient outcomes, the long-term risk of major adverse cardiovascular events (MACE) driven by the progression of non-target lesions (NTLs) remains substa…
Sponsor: China-Japan Friendship Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Acupuncture and gloves: a new hope against chemo nerve pain?
Prevention Recruiting nowAs a core component of comprehensive breast cancer treatment, chemotherapy frequently induces chemotherapy-induced peripheral neuropathy (CIPN), particularly with taxane-based agents. The incidence of CIPN reaches 68.1% within the first month of chemotherapy, and over 30% of pati…
Phase: NA • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
New hope for stomach cancer: Real-World study explores better Second-Line treatments
Disease control Recruiting nowThis study is an open-label, multi-cohort real-world research that explores the efficacy and safety of different second-line treatment regimens for gastric/gastroesophageal junction adenocarcinoma that has failed first-line fluoropyrimidine, platinum-based chemotherapy combined w…
Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can VR games sharpen the minds of people with mental illness?
Symptom relief OngoingThis randomized controlled trial aims to evaluate the effectiveness of a virtual reality-based cognitive remediation (VRCR) intervention in improving cognitive performance and psychosocial functioning in individuals with schizophrenia spectrum disorders (SSD) and bipolar disorder…
Phase: NA • Sponsor: Università degli Studi di Brescia • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC